Jul 30 |
Teva Pharmaceutical Q2 2024 Earnings Preview
|
Jul 29 |
Hospital Business Recovery to Aid Haemonetics' (HAE) Q1 Earnings
|
Jul 29 |
Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics
|
Jul 29 |
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
|
Jul 26 |
Teva's Q2 Outlook: Key Developments In Biosimilars And Pipeline Drugs
|
Jul 25 |
Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease
|
Jul 22 |
Why Hims & Hers Heath Shares Are Surging Today
|
Jul 19 |
TEVA's Ajovy Meets Goal in Migraine Prevention Study for Kids
|
Jul 19 |
Teva reports positive data from Phase III paediatric migraine prevention trial
|
Jul 18 |
Teva meets main goal in trial for its migraine prevention in children and adolescents
|